Ampersand Biosciences has been awarded the SBIR Grant for 2022 for immunologic analysis of non-mammalian and underrepresented mammalian models such as hamster.
Species: Hamster
Focus: Severe infectious diseases, Influenza, SARS-CoV-2
Ampersand Biosciences was featured as a news story in the NNY360 about its formation as a biomedical research and development company and it’s dedication to performing contract work for medical research businesses.
Ampersand Biosciences was featured as a news story in the NCPR about its formation as a new biotech company that will stay in Saranac Lake.